Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
Dec 05, 2019

Our drug discovery and development engine has the scope and scale to innovate the next generation of medicines. We’re harnessing powerful and advanced therapy platforms to take on big scientific challenges and find opportunities to develop breakthrough medicines for patients.

Learn more in our media release.

R&D and Investor Update

Download the presentation (PDF 8.1 MB)

Novartis R&D on Social Media

We have the scope and scale to take on big scientific challenges in our quest to deliver innovation for patients. #ReimaginingMedicine
— Novartis Science (@NovartisScience) December 5, 2019

View this post on Instagram

You need a passionate and innovative team to build out one of the most innovative pipelines in the industry, and some of them are pictured here. As Novartis wraps up a breakthrough year during which we had six new medicines approved—a rare scientific feat—we're gathering in London today to share a deeper look at our R&D efforts. I'm grateful we could share this moment together and look forward to our continued work to reimagine medicine for the world. #novartis #reimaginingmedicine
A post shared by Vas Narasimhan (@vasnarasimhan) on Dec 5, 2019 at 5:55am PST 


Reimagine medicine with Novartis

Find career opportunities in research and development at Novartis.

Learn More